Nuzenio

Autolus Therapeutics

Autolus Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Autolus Therapeutics (AUTL) Tops Q2 EPS by 8c - StreetInsiderStreetInsider · Tue, 11 Aug 2026 11:18:11 GMT Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Caledonian RecordCaledonian Record · Tue, 11 Aug 2026 11:02:46 GMT Renaissance Technologies LLC Has $3.17 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeatMarketBeat · Sun, 09 Aug 2026 08:43:59 GMT Autolus Therapeutics plc (AUTL) Stock Analysis: Biotechnology Innovator with 333% Potential Upside - DirectorsTalk InterviewsDirectorsTalk Interviews · Fri, 07 Aug 2026 09:20:24 GMT Autolus Therapeutics (AUTL) Institutional Ownership 2026 $AUTL - MarketBeatMarketBeat · Fri, 07 Aug 2026 07:00:00 GMT Watkins Advises Perceptive Advisors on Growth Financing for Leading Oncology Biotech Autolus Therapeutics - Latham & Watkins LLPLatham & Watkins LLP · Tue, 04 Aug 2026 16:34:38 GMT Autolus Raises AUCATZYL Outlook, Secures New Credit Facility - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 12:34:00 GMT Autolus Therapeutics to report Q2 2026 financia... - pluang.compluang.com · Tue, 04 Aug 2026 04:10:11 GMT

Timeline

Tue, 11 Aug 2026 11:18:11 GMTAutolus Therapeutics (AUTL) Tops Q2 EPS by 8c - StreetInsider

Tue, 11 Aug 2026 11:02:46 GMTAutolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Caledonian Record

Sun, 09 Aug 2026 08:43:59 GMTRenaissance Technologies LLC Has $3.17 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat

Fri, 07 Aug 2026 09:20:24 GMTAutolus Therapeutics plc (AUTL) Stock Analysis: Biotechnology Innovator with 333% Potential Upside - DirectorsTalk Interviews

Fri, 07 Aug 2026 07:00:00 GMTAutolus Therapeutics (AUTL) Institutional Ownership 2026 $AUTL - MarketBeat

Tue, 04 Aug 2026 16:34:38 GMTWatkins Advises Perceptive Advisors on Growth Financing for Leading Oncology Biotech Autolus Therapeutics - Latham & Watkins LLP

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

AUTL14 live mentions Autolus Therapeutics Reports4 live mentions Stock Analysis4 live mentions Therapeutics4 live mentions Net Product Revenue4 live mentions Preliminary Second Quarter3 live mentions Tops2 live mentions EPS2 live mentions Financial Results2 live mentions Quarter2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Autolus Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.